Health and Healthcare
699 Articles
Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis…
After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s…
These are not all of the upgrades or positive calls we have seen, but these are some calls moving shares…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…
Based on data from Nasdaq as of June 13, short sellers made heavy bets against tech stocks. Many investors clearly…
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that…
Amgen (AMGN) adjusted earnings per share of $1.12 for the first quarter of 2008, an increase of 4 % compared…
This week felt like a yo-yo of volatility, and frankly that makes it even better that it was a 4-day…
These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE:…
It almost seems that no matter what happens, there are always some major companies whose shares just won’t recover when…
Biotech’s are sliding along with all the others today. A look at the highlights and outliers: Amgen (NASDAQ: AMGN) and…
According to Reuters, regulators unveiled a plan to toughen rules for mortgage brokers. Reuters writes that Yahoo! (YHOO) and Microsoft…
Two of the best-selling drugs in the US are Procrit from Johnson & Johnson (NYSE: JNJ) and Aranesp from Amgen…
According to Reuters, weak confidence and rising prices are fuelin stagflation fears. Reuters writes that the long fight between Microsoft…
Below are some of the top issues affecting biotech shares today: AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing…
Our top personal finance-related articles today. Your wallet will thank you later.